Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once vs. twice daily bisoprolol for AF prevention post-CABG
NCT05730413Phase 4Unknown
- Sponsor
- Cairo University
- Start
- Aug 2021
- Primary completion
- Sep 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bisoprolol in Atrial fibrillation (AFib), sponsored by Cairo University. Status: unknown.
02
Drugs
bisoprolol
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT05730413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05730413.